Compare INVA & STEW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | INVA | STEW |
|---|---|---|
| Founded | 1996 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.8B |
| IPO Year | 2000 | 1996 |
| Metric | INVA | STEW |
|---|---|---|
| Price | $20.61 | $17.45 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $35.00 | N/A |
| AVG Volume (30 Days) | ★ 733.2K | 49.5K |
| Earning Date | 11-04-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 816.67 | N/A |
| EPS | ★ 1.25 | N/A |
| Revenue | ★ $217,217,000.00 | N/A |
| Revenue This Year | $9.72 | N/A |
| Revenue Next Year | $8.58 | N/A |
| P/E Ratio | $16.88 | ★ N/A |
| Revenue Growth | ★ 62.63 | N/A |
| 52 Week Low | $16.52 | $16.55 |
| 52 Week High | $25.15 | $19.05 |
| Indicator | INVA | STEW |
|---|---|---|
| Relative Strength Index (RSI) | 50.35 | 26.07 |
| Support Level | $20.39 | $16.55 |
| Resistance Level | $21.73 | $17.79 |
| Average True Range (ATR) | 0.47 | 0.18 |
| MACD | 0.04 | -0.07 |
| Stochastic Oscillator | 66.39 | 3.18 |
Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.
SRH Total Return Fund, Inc. is a non-diversified closed-end management investment company. The company's investment objective is to seek total returns. Its fund utilizes a bottom-up, value-driven investment process to identify securities of good quality businesses trading below estimated intrinsic value. The Funds are available as an actively-managed closed-end fund, an actively managed ETF and a passively-managed ETF.